Latest

PT-141 (bremelanotide) is a synthetic melanocortin peptide that acts centrally on hypothalamic MC3R and MC4R receptors to increase sexual desire and arousal in both men and women, representing the first non-hormonal, centrally acting treatment for sexual dysfunction.

KPV is a tripeptide fragment of alpha-MSH that penetrates cell nuclei to directly suppress NF-kB inflammatory signaling, delivering potent anti-inflammatory effects without the hormonal side effects of its parent molecule or the risks of corticosteroids.

The CJC-1295 No DAC / Ipamorelin blend: GHRH analog + selective ghrelin mimetic for synergistic, pulsatile GH release mimicking natural patterns. One of the most popular combos in longevity & performance medicine.

Retatrutide is a first-in-class, once-weekly injectable peptide that activates GLP-1, GIP, and glucagon receptors simultaneously. It delivers superior weight loss and metabolic benefits compared to prior drugs, approaching results once limited to bariatric surgery.

The Glow Blend combines BPC-157, Thymosin Beta-4, and GHK-Cu into a synergistic trio targeting skin regeneration, collagen remodeling, wound healing, and systemic tissue repair — addressing the cellular and extracellular mechanisms of aging skin from three distinct and complementary angles.

Growth hormone peptides span a wide spectrum — from conservative GHRH analogs approved for clinical use to aggressive secretagogue stacks favored by those seeking maximum output — and understanding how they differ is the first step to using any of them intelligently.

Ipamorelin is a selective growth hormone secretagogue that stimulates pulsatile GH release through the ghrelin receptor without raising cortisol, prolactin, or other stress hormones that limit older compounds in its class.